Evidence map›Paper›PMID 36997540›Full record

ArticleNature communications2023

Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia.

Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Benedicte Sjo TislevollCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-4962-997X
Monica HellesøyDepartment of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway.ORCID http://orcid.org/0000-0002-0115-7427
Oda Helen Eck FagerholtCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-5712-8860
Stein-Erik GullaksenDepartment of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway.
Aashish SrivastavaGenome Core Facility, Clinical Laboratory, K2 Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0003-0532-3979
Even BirkelandThe Proteomics Facility of the University of Bergen (PROBE), University of Bergen, Bergen, Norway.
Dimitrios KleftogiannisCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-1086-821X
Pilar Ayuda-DuránDepartment of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.ORCID http://orcid.org/0000-0002-9799-3680
Laure PiechaczykDepartment of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.
Dagim Shiferaw TadeleDepartment of Molecular Genetics, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8319-678X
Jørn SkavlandCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
Panagotis BaliakasDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-5634-7156
Randi HovlandCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0001-8543-2213
Vibeke AndresenCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-2368-2978
Ole Morten SeternesDepartment of Pharmacy, UiT-The Arctic University of Norway, 9037, Tromsø, Norway.ORCID http://orcid.org/0000-0001-8537-3612
Tor Henrik Anderson TvedtDepartment of Hematology, Oslo University Hospital, Oslo, Norway.
Nima AghaeepourDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94121, USA.ORCID http://orcid.org/0000-0002-6117-8764
Sonia GavassoCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
Kimmo PorkkaDepartment of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.ORCID http://orcid.org/0000-0003-4112-5902
Inge JonassenCentre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-4110-0748
Yngvar FløisandCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.ORCID http://orcid.org/0000-0001-7267-1944
Jorrit EnserinkDepartment of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.ORCID http://orcid.org/0000-0002-2394-5387
Nello BlaserDepartment of Informatics, University of Bergen, Bergen, Norway. nello.blaser@uib.no.ORCID http://orcid.org/0000-0001-9489-1657
Bjørn Tore GjertsenCentre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.gjertsen@uib.no.ORCID http://orcid.org/0000-0001-9358-9704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36997540
PMCPMC10063685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.